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Acceptance and adoption of biofortified crops 
in low- and middle-income countries
Records identified through database searching
n = 1563
Additional records identified through other sources
n = 106
Records after duplicates removed 
n = 1574
Records screened
n = 1574
Excluded
n = 1274
Full-text articles assessed for eligibility 
n = 300
Excluded because:
 - Not about biofortification with micronutrients:  29
 - Not a human study:  59
 - Not a low income country:  14
 - Not in English or Spanish:  7
 - Not about acceptability:  79
 - Not original research:  38
 - Insufficient data:  1
 - No access to paper:  1
Total: 228
Studies included in qualitative synthesis 
n = 72
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Introduction 
Biofortification of staple crops through con-
ventional plant breeding, genetic engineering 
or agronomic approaches, is a promising strat-
egy for increasing dietary nutrient density to 
improve human health. Successful implemen-
tation depends, amongst others, on willingness 
of consumers and farmers to accept the newly 
bred crop varieties. 
Objective  
In this systematic review, we summarize studies 
assessing the sensory acceptance and adop-
tion of biofortified crops and the determining 
factors among consumers and farmers in low- 
and middle-income countries. 
Methods  
We used the electronic databases of Pubmed, 
Scopus and Web of Science for the system-
atic review with two key topics combinations 
of 1) Biofortification, and 2) Acceptance OR 
Adoption, combined with the identification of 
unpublished or ongoing studies through con-
tacting key organizations and biofortification 
experts yielded 1669 records (December 2015). 
Applying exclusion criteria resulted in a final 
selection of 72 papers and the exclusion crite-
ria comprised: 
 - not about biofortification with micronutrients
 - not a human study
 - not a low-and middle-income country
 - not a staple crop (as defined in the search 
strategy: maize, cassava, sweet potato, 
potato, pearl millet, bean, sorghum, rice)
 - a language other than English or Spanish
 - no mention of acceptability
 - no original research
Results
Most studies were found on sensory acceptability (n=40), followed by consumer adoption (n=26) and lastly 
by determinants of acceptance (n=20) and focused on cassava, orange flesh sweet potato, maize, rice, beans 
and pearl millet. Sweet potato and maize are crops most studied, with rice and pearl-millet least investigated. 
Overall sensory acceptance was good, and availability and information on health benefits are the most im-
portant determinants of acceptance and adoption. 
Conclusion
From a sensory perspective, biofortified crops are well accepted by rural and urban populations. Even a vis-
ible trait such as (yellow) color does not seem to be a major obstacle in itself. Availability of the crop and in-
formation on health benefits are among the most important determinants of acceptance and adoption of bio-
fortified crops. Most studies do indicate that there is need for segmented targeted communication strategies 
due to the preference heterogeneity of respondents studied. However, in many of the studies reviewed here, 
biofortified crops were not yet available and acceptance remained hypothetical. Data on actual adoption are 
only available for sweet potato and to a lesser extent for yellow maize based on large effectiveness studies. 
Future studies should look into the actual determinants of adoption during and after wide scale introduction 
of biofortified beans, cassava, rice and pearl millet.
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